Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8M Buy
5,417
+501
+10% +$797K 0.15% 117
2026
Q1
$6.49M Buy
4,916
+371
+8% +$508K 0.1% 137
2025
Q4
$4.86M Sell
4,545
-80
-2% -$83.5K 0.08% 160
2025
Q3
$4.48M Buy
4,625
+522
+13% +$410K 0.07% 167
2025
Q2
$3.29M Buy
4,103
+289
+8% +$207K 0.06% 182
2025
Q1
$2.53M Buy
3,814
+31
+0.8% +$22.6K 0.05% 195
2024
Q4
$2.62M Buy
3,783
+1,838
+94% +$1.32M 0.05% 187
2024
Q3
$1.62M Buy
1,945
+507
+35% +$453K 0.03% 226
2024
Q2
$1.47M Hold
1,438
0.03% 227
2024
Q1
$1.4M Buy
1,438
+302
+27% +$268K 0.03% 231
2023
Q4
$860K Buy
1,136
+189
+20% +$125K 0.02% 264
2023
Q3
$557K Buy
947
+458
+94% +$304K 0.02% 302
2023
Q2
$354K Buy
+489
New +$332K 0.01% 366

Other funds holding ASML

Glenview Trust's ASML Position: Q2 2026 in Review

Glenview Trust increased its ASML (ASML) stake by 10% in Q2 2026, buying an estimated $797K and bringing the position to 5,417 shares worth $10.8M. The position accounts for 0.15% of the portfolio, ranked #117.

Glenview Trust first reported a position in ASML in Q2 2023 and has held it in 13 quarters since. 2,501 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Glenview Trust held 5,417 shares of ASML worth $10.8M as of Q2 2026.
  • Glenview Trust bought 501 ASML shares in Q2 2026, an estimated $797K.
  • ASML made up 0.15% of Glenview Trust's portfolio in Q2 2026, its #117 holding.
  • Glenview Trust first reported a position in ASML in Q2 2023 and has held it in 13 quarters since.
  • 2,501 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.